Biotechnology Companies Worldwide
Biotechnology companies develop, manufacture, and distribute medical devices, diagnostics, or pharmaceutical products for use in clinical, hospital, and research settings. This page lists companies operating in the Biotechnology sector based on self-reported profile data. No companies currently match this exact sector selection on Enterprise League. Browse related sectors or submit a company to the directory.
764 companies
Location
Category
Biotechnology
List of Biotechnology companies in All locations
764 companies
Sort by
Inseco is an insect protein company based in Cape Town, South Africa. Using the power of Black Soldier Flies, Inseco converts low-value organic by-products into insect-based proteins, lipids, fertiliser and chitosan. Our products have numerous applications in animal feed, pet food, crop production, cosmetics and pharmaceuticals. Using cutting-edge technology, we are responding to the demand for sustainable and high-quality ingredients to feed a rapidly growing global population. Throughout the supply chain, various forms of organic by-products are generated that are typically sent to landfills at significant cost. At Inseco, we have developed an entirely new way to solve this problem, helping businesses divert waste from landfill, generate new revenue streams and positively contribute to their carbon footprint. Inseco is a mission-driven business with a focus on supplying high quality insect ingredients to various markets, locally and internationally.
Biotechnology
Livestock and Livestock Services
Agricultural Equipment and Supplies
Cell-Easy developed a unique vision of CDMO dedicated to the production of Cell-based Therapy products, this integrated concept is called CDMAO.
Beyond conventional CDMO, Cell-Easy is not only focusing on Development & Manufacturing but we are positioning as a real partner for helping Biotech & Pharma to bridge the gap between preclinical and clinical development with in depth expertise on regulatory process scale-up and analytics.
Cell-Easy offers customized process development, process scale-up, cGMP manufacturing and unique analytical services for immune cells (engineered CAR-T, NK, …cells, and non-engineered cells) and adult stem cells (MSCs, iPSCs and Exosomes) in both Immuno-Oncology and Regenerative Medicine fields.
Cell-Easy is a trusted partner and brings today the infrastructure and know-how while ensuring your projects are delivered on time and budget. Supported by highly motivated and experienced people in the Cell Therapy field, Cell-Easy is committed to driving service excellence and actively contribute to a “Bench to Bedside” culture, putting the health care of patients at the heart of everything.
Biotechnology
Healthcare
Celtic Renewables Limited is an innovative and award-winning company formed to commercialise a process for producing a superior next-generation biofuel (and other high-value sustainable products) from the by-products of biological industries.
Further information at www.celtic-renewables.com
Follow us on Twitter @CRL_UK
Follow us on Facebook @celticrenewables
Follow us on Instagram @celticrenewables
Biotechnology
Renewable Energy
Innovation Management
Manufacturing
Harnessing the power of deep learning on 3D molecular configurations to deliver medicines of transformational efficacy to patients.
Artificial Intelligence
Life Science
Market Research
Biotechnology
Hemispherian is a biotechnology company developing new treatments for the most aggressive types of cancer.
Our mission is to develop a new drug to treat Glioblastoma Multiforme.
We aim to significantly increase life expectancy for patients, improve patient comfort, and generally increase the overall survival rates for GBM patients.
Health and Medical Products
Business Consulting
Healthcare
Health Centers
Management Consulting
Biotechnology
In Ovo combines animal welfare and efficiency by offering biotechnological solutions to the poultry industry. We currently focus on a long existing problem in hatcheries: The culling of one day old male chickens. Our solution, a gender screening in the first half of the breeding process, has several advantages. It prevents a lot of stress the chickens experience during the current manual gender sorting process, it reduces the energy consumption and CO2 emission of the hatchery and prevents the need to kill one day old chickens. This way, we make hatcheries more animal friendly and sustainable, and increase the efficiency at the same time.
Veterinary Services
Sustainability
Healthcare
Biotechnology
inHEART is committed to delivering the world’s most sophisticated, AI-enabled, digital twin of the heart to advance the care of patients living with cardiac disease. We believe all patients deserve access to world-class expertise that guides and optimizes treatment strategies to support improved clinical outcomes and return patients to full, healthy lives.
Medical Equipment and Services
3D Technology
Health and Medical Products
Biotechnology
WE ARE CREATING THE FUTURE OF HEALTH
DISPENDIX provides premium liquid handling technology to scientists and lab technicians around the world, and is creating the future of medicine. Liquid handling technology enables new discoveries in areas such as drug development, diagnostics and synthetic biology. We believe that technological advances and science are made for each other. Good technology simplifies science. DISPENDIX GmbH, the premier provider of noncontact liquid handling solutions in the nano to microliter range, started out in 2016 as a spin-off from the Fraunhofer Institute for Manufacturing Engineering and Automation (IPA) in Stuttgart, Germany. In 2018, DISPENDIX joined the world’s leading bio convergence company BICO, which now encompasses 900+ colleagues and 11 companies, offering a portfolio of technologies, products and services to create the future of health. Part of that portfolio is DISPENDIX’s award winning patented and widely recognized technology, the I.DOT (Immediate Drop-on-demand Technology), which brings intuitive automation, precision and speed to every lab, allowing scientists to optimize liquid handling workflows and accelerate their research in a range of applications.
Biotechnology
StarkAge Therapeutics is a privately-held biotechnology start-up, whose ambition is to delay or halt disease progression and improve quality of life of patients with age-related diseases, associated with senescent cells accumulation.
It builds on its unique disease-specific exosomal / EV technology while harnessing immunotherapy approach, to address very large senescence unmet medical needs.
Medical
Biotechnology
Subitec is a solution provider covering its customers’ needs in leading edge industrial turnkey production plants and related supporting systems based on proprietary Flat Panel Airlift (FPA) photobioreactors-technology.
More than twenty years ago Subitec started its activities with a strong focus on better understanding prerequisites and conditions of microalgae and cyanobacteria cultivation. Backed by this research know-how, Subitec nowadays has installed more than 50 production plants and supporting systems equipped with our proprietary FPA photobioreactors all over the world.
Food Processing
Cosmetics
Machinery Manufacturing
Advanced Materials
CleanTech
Biotechnology
Artios is a leading independent DNA Damage Response (DDR) company focused on developing first-in-class treatments for cancer. Artios began clinical trials in February 2021 of its small-molecule ATR inhibitor, ART0380, in patients with advanced or metastatic solid tumours.
Established in May 2016, the Company is led by an experienced scientific and leadership team with proven expertise in DDR drug discovery and PARP inhibitors; key staff at Artios developed the drug olaparib (Lynparza ™). Artios is building a pipeline of next-generation DDR programmes, including through a unique partnership with Cancer Research Technology (CRT), the development and commercialisation arm of Cancer Research UK (CRUK), with leading DNA repair researchers worldwide. The Company’s investors include SV Life Sciences, Merck Ventures, Imperial Innovations, Arix Bioscience PLC, CRT Pioneer Fund (managed by Sixth Element Capital), and AbbVie Ventures. Artios is based at the Babraham Institute in Cambridge, UK.
Biopharma
Medical Equipment and Services
Health and Medical Products
Biotechnology
We are Bicycle Therapeutics, a clinical-stage biopharmaceutical company. We didn’t wait for the next advance against cancer. We created it.
Based on groundbreaking work conceived in the laboratory of Sir Greg Winter with the help of Professor Christian Heinis, we are pioneering the development of bicyclic peptides, or Bicycles® – a novel class of versatile, chemically synthesized medicines. Bicycles are fully synthetic short peptides constrained to form two loops which stabilize their structural geometry. This constraint is designed to confer high affinity and selectivity, and the relatively large surface area presented by the molecule allows targets to be drugged that have historically been intractable to non-biological approaches. Bicycles represent a unique therapeutic class, combining the pharmacological properties normally associated with a biologic with the manufacturing and pharmacokinetic advantages of a small molecule, yet with no signs of immunogenicity observed to date.
Bicycles can be used as Bicycle conjugates to deliver toxin payloads and to precisely target local immune activation within tumors and as Bicycle T-cell modulators, which activate cytotoxic T-cells while circumventing the limitations of antibody and biologic therapies and better enabling combination therapy. Our lead product candidate, BT1718, is a Bicycle toxin conjugate currently being investigated in a Phase I/IIa open label dose escalation and expansion clinical trial sponsored by Cancer Research UK. BT1718 targets Membrane Type 1 Matrix Metalloproteinase (MT1-MMP), also known as MMP-14, which is highly expressed in many solid tumors.
Our strategic collaborations are based on the ability of Bicycles to address a wide variety of targets. Through collaborations with AstraZeneca, Oxurion, Innovate UK and the Dementia Discovery Fund, we work with companies that have deep therapeutic expertise outside of oncology to enable us to more efficiently develop novel medicines for patients.
Medical Equipment and Services
Therapeutics
Health and Medical Products
Biotechnology
bit.bio is an award-winning human synthetic biology enterprise. Our mission is coding cells for health. To do so, we apply the principles of computation to biology.
Our current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. This has the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies.
To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modelling, and cell therapy.
Collaboration is at the heart of bit.bio. We are empirical, highly ambitious and driven by a common purpose.
Commercial
Biotechnology
Healthcare
Innovative polish company offering monitoring wristbands and telemedine platform to hospitals, institutions, idividuals
SiDLY initiates the development of medical telematics in Poland and Europe. SiDLY sp.z o.o. as one of the first organizations, deal comprehensively with medical diagnostics from the distance, starting from the search of areas requiring initiating telematics solutions through design, testing and constructing of both- devices and systems, and the dedicated application. SiDLY team, consists of the representatives of technology, medicine and science.
The products of SiDLY improve the work of clinics and houses of Social Welfare. They also enable a remote medical diagnostics for individual costumers. Telemedical platform with wristbands is implemented in hospitals, including contagious departures.
Health and Medical Products
Medical
Medical Equipment and Services
Biotechnology
Healthcare
Abionic, an in vitro diagnostics (IVD) company, was founded in 2010 as a spin-off from the Swiss Federal Institute of Technology of Lausanne (EPFL).
Abionic is aiming to make a difference in patient care through the cutting-edge nanofluidic technology based ultra-rapid diagnostic platform, helping healthcare professionals to make clinical decisions at the point of care.
Life Science
Medical
Medical Equipment and Services
Nanotechnology
Pharmaceutical
Biotechnology
Healthcare
Atlantic Instrument For Research (AI4R) is the world leader in digital real-time autoradiography, a new-generation imaging solutions for preclinical studies.
Our company has designed a new autoradiograph: the BeaQuant.
Our device uses an innovative technology (gaz detection) to give researchers a quantitative mapping of radioactivity in a sample (alpha and beta radioisotopes) .
Users will experience the highest resolution in the market for autoradiographic analysis, shorter acquisition time, complete safety and unique versatility (with features such as: QWBA or dual-isotope analysis).
The BeaQuant is the perfect tool to establish in vitro–in vivo correlation.
If you are interested in learning more about our technology, please feel free to visit our website and contact us!
Medical
Biotechnology
aptaTargets is a clinical stage biopharmaceutical company focused in developing therapeutic applications based on aptamer technology. Our candidates are neuroprotectants and immunomodulators being developed from preclinical stages up to clinical proof-of-concept.
Biopharma
Pharmaceutical
Biotechnology
Blue Planet Ecosystems builds, develops and operates modular LARA (Land-based Automated Recirculating Aquaculture) systems for sustainable seafood production in extreme environments. We help farmers, agriculture businesses and future entrepreneurs to diversify their farming methods in the face of climate change.
Food Vendors
Agriculture
Biotechnology
Our ambition is to play a key role in tackling climate change, by enabling green chemistry for every industry. We do this by creating the most general and efficient technology platform for chemical production that the world has ever seen. That’s a big claim, but we can stand behind it. By bio-upgrading the chemical industry with our cell-free biomanufacturing platform, we can produce the products that modern society relies on in a truly sustainable way. The technology platform utilises nature’s catalysts, enzymes, by combining the power of biology with the efficiency of the chemical industry in a best-of-both-worlds solution.
EnginZyme is recognised as a Technology Pioneer by World Economic Forum and backed by Sofinnova Partners, Industrifonden, SEB Greentech VC, Bunge Ventures, Almi Invest GreenTech Fund, and Navigare Ventures.
Manufacturing
Life Science
GreenTech
Biotechnology
We develop first-in-class biologics for several underserved autoimmune conditions. Our therapeutic approach aims to preserve and re-establish organ cell function, transforming the treatment paradigm for intractable autoimmune diseases
Life Science
Healthcare
Pharmaceutical
Biotechnology
Manufacturing
Evotec is a life science company with a unique business model focused on delivering highly effective new therapeutics to the patients.
The Company leverages its multimodality platform, the “Data-driven R&D Autobahn to Cures”, for proprietary projects and within a network of partners including Pharma, Biotech, academics, and other healthcare stakeholders.
With more than 4,500 highly qualified people at 17 sites, Evotec aims to create the world-leading co-owned pipeline for innovative therapeutics.
Therapeutics
Healthcare
Pharmaceutical
Biotechnology
Anjarium Biosciences AG is a genetic medicines company focused on creating and delivering a new generation of targeted gene therapies to patients. Anjarium’s versatile platform builds on novel therapeutic payloads and delivery technologies, with the aim to unlock the full potential of gene therapy.
Pharmaceutical
Biotechnology
BenevolentAI (AMS: BAI) is a leading, clinical-stage AI-enabled drug discovery and development company listed on the Euronext Amsterdam stock exchange. Through the combined capabilities of its AI platform, scientific expertise, and wet-lab facilities, BenevolentAI is well-positioned to deliver novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform™ powers a growing in-house pipeline of 13 named drug programmes and over 10 exploratory programmes, and it maintains successful collaborations with AstraZeneca, as well as leading research and charitable institutions. BenevolentAI is headquartered in London, with a research facility in Cambridge (UK) and a further office in New York.
*Reach out to us*
Email: hello@benevolent.ai
Careers: Careers@benevolent.ai
Twitter: @benevolent_ai
Website: benevolent.com
Artificial Intelligence
Machine learning
Big Data and BI
Biotechnology
Pharmaceutical
Software
By targeting the DNA damage response (“DDR”) in cancer cells, Breakpoint Therapeutics aims to advance to clinical development first-in-class oncology drugs that interfere with DNA repair and replication stress tolerance
pathways. Our mission is to develop drugs that succeed and complement PARP inhibitors and facilitate the cure of therapy resistant cancers.
Biotechnology
To contact us : contact@calixar.com
CALIXAR, is a biotech company specialized in the functional and native isolation of complex membrane therapeutic targets and antigens.
We develop and implement chemistry and biochemistry tools to isolate in solution - with the highest purity levels - full-length membrane proteins, while keeping their structural and functional integrity. Our approach represents the opportunity for pharmaceutical companies to start and work with high quality targets or antigens before developing antibodies, formulating vaccines and/or discovering a primary lead through Structure Based Drug Design or High Throughput Screening assays.
As membrane proteins represent more than 60% of pharmaceutical drug targets, to keep their native conformation during the extraction from membrane cells and solubilization is crucial.
Our technological platform preserves the original structure of membrane proteins such as GPCRs, Ion channels, Transporters, Viral targets, etc.) or others native receptors acting as drug targets or antigens. As a result, this most accurate targeting helps biotechs, academic teams, pharmaceutical industries to develop highly potential drugs, bio drugs and vaccines and consequently saves significant time and money in further clinical stages.
By using original chemistry and specific approaches designed on demand, we develop new tools and protocols for the identification, expression, extraction, purification and crystallization of these membrane proteins/antigens from cells or from endogenous materials (virus, bacteria, primary cells, organs, etc.).
For SBDD/FBDD approaches, we carry out crystallization tests and structure determination of these native targets starting from their full-length and functional version without any point mutations or deletions.
CALIXAR sets up specific R&D programs with its customers using classical and flexible business model: Fee for service, Risk sharing, Exclusivity option and Licensing out.
Therapeutics
Pharmaceutical
Biotechnology
CardiaTec is applying artificial intelligence on large-scale human multi-omics data to develop the next generation of cardiovascular disease drug targets.
Artificial Intelligence
Life Science
Biotechnology
CUBIQ FOODS | Transforming the future of nutrition
We are on a mission to improve nutrition around the world.
Everything we do is focused on radically improving sustainability, health and nutritional profile, with affordability in mind. We also prioritize the consumers’ organoleptic experience across as many products as possible.
As an international food tech company, we combine our scientific knowledge and expertise with the latest advances to provide an innovative range of alternative fats.
We lead in three distinct processes; a novel oil/water emulsion, Omega-3 micro-encapsulation techniques, and the first cell-culture platform for specialty fats (cell-based Omega-3).
Our solutions to the food industry support the development of high-quality processed food. We achieve this by reducing animal and saturated fats while retaining flavor and texture. We deliver health and nutritional benefits and reduce the calorie content.
Our innovative platforms can tune for hardness, texture, and flavor as well as fat content in bespoke product applications.
We produce and sell at scale and license production to select producers worldwide.
Let’s change food from the inside!
Food Manufacturing
Food Vendors
Beverage Production and Manufacturing
Robotics
Biotechnology
CV6 Therapeutics is an early stage drug development company focused on the discovery, development and commercialization of novel combination therapies for the treatment of cancer.
For further investment questions or opportunities please contact: information@cv6t.com
Healthcare
Pharmaceutical
Biotechnology
Manufacturing
AFYX Therapeutics is a private biopharmaceutical company focused on innovative approaches to treat mucosal diseases.
The Company has developed the Rivelin patch, a breakthrough therapy for the treatment of mucosal diseases. Rivelin is designed to deliver a pharmaceutical drug uni-directionally to a mucosal surface using an occlusive, bio-adhesive and bio-degradable patch, with a long adhesion time and a high flexibility, conforming to the mucosal surface.
AFYX's lead Rivelin patch product candidate seeks to treat the auto-immune, inflammatory disease oral lichen planus (OLP) through direct delivery of the drug clobetasol propionate. OLP may appear as lesions in the mouth that may cause burning, pain and other discomfort. OLP is considered an autoimmune disorder and requires regular monitoring given patients have increased risk of developing mouth cancer in the affected areas. No U.S. Food and Drug Administration (FDA) approved treatment exists, with today’s off-label treatment ranging from topical corticosteroids to laser ablation. It is estimated that OLP affects 1% to 2% of the population.
Following successful results from a Phase 1b clinical study of the non-drug-loaded Rivelin patch in patients with OLP, AFYX has begun a Phase 2b clinical study of the clobetasol-loaded Rivelin patch in the United States and various countries in Europe.
Shareholders include Sofinnova Ventures, Lundbeckfonden Emerge, Novo Seeds and Welfare Tech Invest.
Shipping and Delivery
Healthcare
Therapeutics
Clinical Trials
Pharmaceutical
Biotechnology
Elypta is a Swedish molecular diagnostics company focused on reducing cancer mortality through early detection. Elypta is pioneering a metabolism-based liquid biopsy and measures the GAGome – system biomarkers of tumor metabolism. Machine learning algorithms are then used to detect signatures of cancer noninvasively. Elypta is advancing a broad clinical program across different cancers with the first indication expected to be early detection of recurrence in renal cell carcinoma.
Several years of research in Nielsen lab at Chalmers University of Technology in Gothenburg, Sweden led to the founding of Elypta in May 2017 by Francesco Gatto and Jens Nielsen.
Health Centers
Healthcare
Health and Medical Products
Biotechnology
Feedect is a leading company in the sustainable food industry, committed to producing high-quality proteins from insects. By leveraging the exceptional nutritional value of insects and their low environmental footprint, Feedect is transforming the way we feed the world.
Our innovative production processes allow us to create a wide range of insect-based products, including protein powders, which are rich in essential amino acids, vitamins, minerals and natural prebiotic compounds.
At Feedect, we believe that sustainable food production is key to preserving our planet and securing a better future for generations to come.
We are proud to be at the forefront of this movement, providing healthy and sustainable food options that contribute to a more responsible and ethical food system.
Join us in our mission to create a more sustainable food future. Follow our page to stay up to date on our latest developments, products and initiatives.
Agriculture
Food Processing
Nutrition
Pet Food
AgTech
Farming Services
Animal Feed
FIRE1 aims to improve patient quality of life, and patient outcomes, while lowering overall healthcare costs.
Health and Medical Products
Medical
Healthcare
Therapeutics
Medical Equipment and Services
Biotechnology
IVF Bioscience aims to help develop the animal IVF market by improving yields through higher success rates. Using the IVF Bioscience media systems, laboratories benefit from our extensive portfolio of knowledge by achieving higher blastocyst rates, more robust blastocysts and thereby higher pregnancy rates.
Biotechnology
Kynos Therapeutics is poised to bring a new generation of potent first-in-class KMO inhibitors to the market - ready to impact on unmet medical needs.
Kynos Therapeutics Ltd. is a Private Limited Company Registered in England and Wales, Company number 12501037
Medical
Therapeutics
Healthcare
Biotechnology
Manufacturing
LIVIN farms empower people to co-create a healthy planet through the development of insect rearing technology.
We are currently working on exciting projects in professional insect breeding.
Sustainability
Food Processing
Biotechnology
GenePlanet is the leading European provider of preventive genetic tests, specialising in NIPT, cancer screening, and lifestyle DNA tests.
With over 15 years of experience in the market, GenePlanet collaborates with over 1000 medical centres, doctors, and insurance companies to provide top-quality tests based on the latest scientific discoveries.
The company’s tests are designed to empower individuals to take control of their and their baby’s health, as well as assist doctors with therapeutic procedures.
GenePlanet adheres to the highest standards of quality and is constantly striving for new discoveries through its research and development efforts.
With a presence in more than 35 countries worldwide and over 100,000 satisfied customers, GenePlanet has been recognised as one of the 1000 fastest-growing companies in the EU by the Financial Times and one of the Top 35 EU Unicorns by the European Commission.
Biotechnology
Rome-based healthtech startup that offers with JuliaOmix™ an ecosystem of AI-powered solutions for genetic analysis and clinical decision support for diseases.
GenomeUp has developed several bioinformatics tools and protocols to make data and metadata - today big health data - traceable, accessible, interoperable and reusable, necessary for researchers and clinicians who want to give an answer to the millions of people who face the odyssey of the diagnosis of a genetic disease, even more so if rare
Medical
Genetics
Healthcare
Software
Artificial Intelligence
Biotechnology
Created in 2001, Genoscreen provides genomic services and innovative solutions in genomics. Our offer addresses academic and industrial research teams which need to analyse DNA and explore its properties. The health, agrofood and environmental sectors are our main markets.
The company’s portfolio includes:
• Services in molecular biology analyses (DNA sequencing, genotyping, detection of gene mutation, metagenomics analysis in complex environment…)
• Innovative kits to standardize and facilitate specific analyses (kit for microorganisms strains tracing, kit for identification of microbial community in all kinds of environment…)
• Expertise and consultancy services for companies which develop projects in genomics
GenoScreen also proposes custom-made trainings to people wishing to learn or improve their level about genomic analyses.
GenoScreen collaborates to international research programs on Alzheimer’s disease, epidemiological surveillance of pathogens and biodiversity.
Key figures:
• 30 employees, doctors, engineers and technicians
• 300 customers across the 5 continents
• 35% of revenues coming from 30 countries outside France
• 30% of revenues dedicated to R&D
Healthcare
Environmental Protection Consulting and Education
Biotechnology
GliaPharm is a Swiss-based biotechnology company that develops treatments for neurological and psychiatric disorders.
GliaPharm's innovative therapeutic approach is to target glial cells, the 'support cells' of neurons, to sustain and enhance brain metabolism in pathological conditions. Our vision is to become a leading biotechnology company with a focus on glia-mediated pathways as agents for neuroprotection and maintenance of cognitive functions.
Healthcare
Biotechnology
Gradientech is a Swedish biotech and diagnostics company dedicated to support the modern microbiology lab with state-of-the-art solutions to facilitate the workflow with time-critical samples. Our product QuickMIC® is an ultra-rapid system for antibiotic susceptibility testing (AST) of positive blood culture samples from sepsis patients. QuickMIC® is a scalable system with each instrument module analysing one sample against multiple antibiotics, well-suited for small and larger clinical laboratories. MIC values are reported in as short as 2 hours, making it more rapid than any other diagnostic system for phenotypic AST on the market.
Gradientech’s technology combines microfluidics with live cell imaging to study cell responses in a linear concentration gradient. Our technology is a perfect match for many biological applications. Gradientech holds an ISO13485 certification.
Life Science
Medical
Healthcare
Medical Equipment and Services
Biotechnology
Our Vision: Our intelligent sensing platforms integrated on all plasma and RF processing equipment to enable atomic-scale engineering for the advancement of nano-technology.
Our Mission: Creating intelligent sensing platforms for advanced plasma and RF manufacturing processes, to improve process performance and reduce product scrap.
Our Purpose: Our company exists because we believe in the science of measurement. We believe that accurate process measurement is critical for the future of nano-scale manufacture, where process stability and repeatability are paramount to delivering the technology of the future. We measure parameters and processes under some of the most extreme environments encountered on earth. We measure things often considered impossible. #MeasuringTheImpossible.
Our value proposition is that we provide you with an independent diagnosis of your process health, using intelligent, network-enabled sensing platforms, in conjunction with our vast experience in RF and plasma systems, to help you solve the most complex processing issues.
Healthcare
Bioinformatics
Biotechnology
Manufacturing
Lightcast is developing a cell manipulation platform that utilises tiny spots of light to control thousands of cells and reagents at once, enabling game-changing workflows for the pharmaceutical industry.
With applications ranging from immuno-oncology to antibody discovery, stem cell production, cell therapy, and cell line development, the Lightcast platform offers unprecedented levels of control.
As Lightcast grows, we’re excited to invite more people to join us on our mission to revolutionise complex cell analysis. If life at Lightcast appeals to you check out the jobs, we currently have available and become a part of something truly meaningful!
Biotechnology
In Lignopure we produce natural degradable biopolymers from non-food sources. Our Lignopure product is the best-of-its-kind lignin, with proven non cytotoxicity and added functionality. No other lignin in the market can offer the safety of Lignopure and the tailored properties achieved through our protected technology.
From the raw material production, we are able to deliver tailored lignin for different applications; these include particles for cosmetics, pharmaceuticals and food supplements. Additionally, our biobased prototypes include insulating materials, biobased polyurethane foams, aerogels and filaments for 3D printing.
GO GREEN!
Manufacturing
Biotechnology
The forest is a renewable resource. Lignin is a by-product from the pulping industry. Globally 80 million tonnes is processed in the pulping industry, making it the largest natural by-product on earth. Today, 99% of the produced lignin is burnt for its energy value.
We, at Lignin Industries, convert lignin so it can be blended with virgin and recycled thermoplastics creating new types of bioplastics. For every 1 kg of fossil based plastics replaced by RENOL® we decrease CO₂ up to 6 kgs released into the atmosphere.
We can provide the plastic industry with large amounts of granulates for several market segments ranging from packaging, agricultural films and injection moulding pieces.
Lignin Industries is one of the few selected companies among 232 proposals to be supported by the European Union Innovation Fund that will co-fund Lignin Industries by financing the expansion of the first-of-its-kind large-scale production site, located in Sweden.
The funding was given under the call “Innovation Fund” with the aim to support projects demonstrating highly innovative technologies and products that have a significant potential to reduce greenhouse emissions.
Biotechnology
Manufacturing
LUMICKS is the leading supplier of dynamic single-molecule and cell avidity analysis instruments. Our instruments enable – for the first time – the analysis of complex dynamic details related to the behavior and interaction of single molecules and cells.
Built upon innovative and Nobel Prize-winning technologies, such as optical tweezers (Nobel Prize for Physics 2018), and STED super-resolution (Nobel Prize for Chemistry 2014), our tools enable the understanding of life to the smallest detail.
Our goal is to advance science and improve human health, by providing tools that unlock the measurement of forces and interactions in biology. For the first time ever, our unapparelled solutions can assist research by directly linking structural and ‘omics analysis to functional outcomes at both a molecular and a cellular level. This is achieved by applying and measuring forces around biological interactions, enabling the detailed real-time analysis of underlying biological mechanisms.
Medical Equipment and Services
Life Science
Health and Medical Products
Biotechnology
Luminate Medical is a healthcare technology company that builds devices to prevent and control the side effects of cancer treatment. Based in Galway, Ireland, Luminate is pioneering the development of Lily, a device to prevent chemotherapy induced hair loss in a comfortable and portable way, and Lilac, the world's first preventative treatment for peripheral neuropathy. Luminate is a VC-backed startup funded by Y Combinator (S21) with multiple successful grant and investment rounds to date.
Health and Medical Products
Medical
Healthcare
Medical Equipment and Services
Biotechnology
Lunaphore Technologies S.A. is a Swiss company born in 2014 with the vision of enabling spatial biology in every laboratory. Lunaphore has developed a game-changing chip technology which can extract spatial proteomic and genomic data from tumors and transform any simple assay into multiplex spatial biology without complexity. Lunaphore empowers researchers to push the boundaries of research to ultimately develop the next generation personalized therapies.
Life Science
Health and Medical Products
Healthcare
Health Centers
Medical Equipment and Services
Biotechnology
Medicilio brings healthcare to patients's homes.
Medical
Healthcare
Medical Professionals
Medical Organisations
Biotechnology
Mental Health Care
MedLumics is a medical device company with the goal of taking the latest technological and scientific developments in biophotonics and turning them into innovative and quality products to improve the quality of life.
Our work is focused on one of the most successful light-based diagnostic techniques, Optical Coherence Tomography, which is currently seeing rapid expansion and growth.
Our disruptive technological advantages allow us to offer unique medical solutions and to develop the clinical applications of this imaging modality.
MedLumics, Enlightening Healthcare
IT Consulting Services
Health and Medical Products
Medical
Healthcare
CRM
Medical Equipment and Services
Hospital
Memo Therapeutics AG is an innovator in the field of antibody discovery and immune repertoire analysis.
Its DROPZYLLA™ platform creates a recombinant in vitro copy of an individual’s B cell / antibody repertoire, which is then banked as a library. The resulting unique, large and relevant antibody libraries represent the individual’s immune repertoire and are expected to contain an unprecedented number of relevant and rare antibodies. Combined with our microfluidic high throughput single cell-based functional screening system this leads to entirely new possibilities in immune repertoire analysis and antibody discovery.
The business strategy of Memo Therapeutics is the discovery of therapeutic antibody candidates and target discovery for antibody and vaccine development. DROPZYLLA™ is deployed in proprietary antibody discovery programs and is made available in collaborations e.g. for screening of CAR-T; TCR-T or bi-specific antibodies.
Collaboration
Biotechnology
Company Name | Location | Category | Employees | Accuracy | Website | |
|---|---|---|---|---|---|---|
Cape Town , South Africa | Science and Engineering +1 Science and Engineering, Agriculture and Livestock | 10-20 | https://www.inseco.co.za | |||
Toulouse, France | Science and Engineering +1 Science and Engineering, Health and Medical | 30-50 | info@cell-easy.com | https://www.cell-easy.com/ | ||
Edinburgh, United Kingdom (UK) | Science and Engineering +3 Science and Engineering, Environment, Professional Services, Manufacturing and Industry | 50-100 | enquiries@celtic-renewables.com | https://www.celtic-renewables.com/ | ||
London, United Kingdom (UK) | Information Technology +2 Information Technology, Science and Engineering, Sales and Marketing | 30-50 | laksh@charmtx.com | https://charmtx.com/ | ||
Oslo, Norway | Health and Medical +2 Health and Medical, Business Services, Science and Engineering | 10-20 | info@hemispherian.com | https://www.hemispherian.com/ | ||
Leiden, The Netherlands | Pets and Animals +3 Pets and Animals, Environment, Health and Medical, Science and Engineering | 10-20 | mail@inovo.nl | https://inovo.nl/ | ||
Pessac, France | Health and Medical +2 Health and Medical, Design Services, Science and Engineering | 30-50 | contact@inheartmedical.com | https://www.inheartmedical.com/ | ||
Stuttgart, Germany | Science and Engineering Science and Engineering | 50-100 | info@dispendix.com | https://dispendix.com/ | ||
Lille, France | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@starkagetx.com | https://starkagetx.com/ | ||
Stuttgart, Germany | Food and Beverages +4 Food and Beverages, Beauty and Personal Care, Manufacturing and Industry, Energy, Science and Engineering | 10-20 | info@subitec.com | https://www.subitec.com/ | ||
Cambridge, United Kingdom (UK) | Health and Medical +1 Health and Medical, Science and Engineering | 50-100 | info@artios.com | https://www.artios.com/ | ||
Cambridge, United Kingdom (UK) | Health and Medical +1 Health and Medical, Science and Engineering | 200-500 | info@bicycletherapeutics.com | https://www.bicycletherapeutics.com/ | ||
Cambridge, United Kingdom (UK) | Sales and Marketing +2 Sales and Marketing, Science and Engineering, Health and Medical | 150-200 | info@bit.bio | https://www.bit.bio/ | ||
Warsaw, Poland | Health and Medical +1 Health and Medical, Science and Engineering | 50-100 | office@sidly.eu | https://sidly.eu/ | ||
Lausanne, Switzerland | Science and Engineering +1 Science and Engineering, Health and Medical | 30-50 | info@abionic.com | https://www.abionic.com/en | ||
Nantes, France | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | contact@ai4r.com | https://www.ai4r.com/ | ||
Madrid, Spain | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@aptatargets.com | https://aptatargets.com/ | ||
Vienna, Austria | Food and Beverages +2 Food and Beverages, Agriculture and Livestock, Science and Engineering | 10-20 | paul@blue-planet-ecosystems.com | https://www.blueplanetecosystems.com/ | ||
Stockholm, Sweden | Manufacturing and Industry +2 Manufacturing and Industry, Science and Engineering, Energy | 50-100 | hello@enginzyme.com | https://enginzyme.com/ | ||
Milan, Italy | Science and Engineering +2 Science and Engineering, Health and Medical, Manufacturing and Industry | 2-10 | info@entherapharmaceuticals.com | https://www.entherapharmaceuticals.com/ | ||
Hamburg, Germany | Health and Medical +1 Health and Medical, Science and Engineering | 5000+ | info@evotec.com | https://www.evotec.com/en | ||
Schlieren, Switzerland | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | info@anjarium.com | https://www.anjarium.com/ | ||
London, United Kingdom (UK) | Information Technology +2 Information Technology, Science and Engineering, Health and Medical | 200-500 | info@benevolent.com | about:blank | ||
Hamburg, Germany | Science and Engineering Science and Engineering | 2-10 | info@breakpointtx.com | https://breakpointtx.com/ | ||
Lyon, France | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | contact@calixar.com | https://www.calixar.com/ | ||
Cambridge, United Kingdom (UK) | Information Technology +1 Information Technology, Science and Engineering | 10-20 | info@cardiatec.ai | https://www.cardiatec.ai/ | ||
Barcelona, Spain | Food and Beverages +2 Food and Beverages, Information Technology, Science and Engineering | 30-50 | amontefeltro@cubiqfoods.com | https://www.cubiqfoods.com/ | ||
Belfast, United Kingdom (UK) | Health and Medical +2 Health and Medical, Science and Engineering, Manufacturing and Industry | 2-10 | information@cv6t.com | http://www.cv6t.com/ | ||
Copenhagen, Denmark | Professional Services +2 Professional Services, Health and Medical, Science and Engineering | 10-20 | inquiry@afyxtx.cominquiry | https://afyxtx.com/ | ||
Stockholm, Sweden | Health and Medical +1 Health and Medical, Science and Engineering | 30-50 | info@elypta.com | https://www.elypta.com/ | ||
Valencia, Spain | Agriculture and Livestock +5 Agriculture and Livestock, Food and Beverages, Health and Medical, Pets and Animals, Environment, Science and Engineering | 10-20 | info@feedect.com | https://feedect.com/ | ||
Dublin, Ireland | Health and Medical +1 Health and Medical, Science and Engineering | 100-150 | info@fire1foundry.com | https://fire1foundry.com/ | ||
Falmouth, United Kingdom (UK) | Science and Engineering Science and Engineering | 2-10 | sales@ivfbioscience.com | https://ivfbioscience.com/ | ||
Edinburgh, United Kingdom (UK) | Health and Medical +2 Health and Medical, Science and Engineering, Manufacturing and Industry | 2-10 | admin@kynostx.com | http://www.kynostx.com/ | ||
Vienna, Austria | Environment +2 Environment, Food and Beverages, Science and Engineering | 10-20 | contact@livinfarms.com | https://www.livinfarms.com/ | ||
Ljubljana, Slovenia | Science and Engineering Science and Engineering | 150-200 | info@geneplanet.com | https://geneplanet.com/eu | ||
Rome, Italy | Health and Medical +3 Health and Medical, Sport and Recreation, Information Technology, Science and Engineering | 30-50 | info@genomeup.com | https://www.juliaomix.com/ | ||
Lille, France | Health and Medical +2 Health and Medical, Environment, Science and Engineering | 30-50 | contact@genoscreen.com | https://www.genoscreen.fr/fr/ | ||
Geneva, Switzerland | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@gliapharm.com | https://new.gliapharm.com/ | ||
Uppsala, Sweden | Science and Engineering +1 Science and Engineering, Health and Medical | 50-100 | sales@gradientech.se | https://gradientech.se/ | ||
Dublin, Ireland | Health and Medical +2 Health and Medical, Science and Engineering, Manufacturing and Industry | 10-20 | chanel.linnane@impedans.com | https://www.impedans.com/ | ||
Cambridge, United Kingdom (UK) | Science and Engineering Science and Engineering | 100-150 | info@lightcastd.com | https://lightcastd.com/ | ||
Hamburg, Germany | Manufacturing and Industry +1 Manufacturing and Industry, Science and Engineering | 10-20 | joana.gil@lignopure.de | https://www.lignopure.com/ | ||
Uppsala, Sweden | Science and Engineering +1 Science and Engineering, Manufacturing and Industry | 20-30 | contact@lignin.se | https://www.lignin.se/ | ||
Amsterdam, The Netherlands | Health and Medical +1 Health and Medical, Science and Engineering | 200-500 | info@lumicks.com | https://lumicks.com/ | ||
Galway, Ireland | Health and Medical +2 Health and Medical, Sport and Recreation, Science and Engineering | 10-20 | info@luminatemed.com | https://www.luminatemed.com/ | ||
Lausanne, Switzerland | Science and Engineering +2 Science and Engineering, Health and Medical, Sport and Recreation | 100-150 | communications@lunaphore.com | https://lunaphore.com/ | ||
Milan, Italy | Health and Medical +1 Health and Medical, Science and Engineering | 30-50 | info@medicilio.it | https://www.medicilio.it/ | ||
Madrid, Spain | Business Services +4 Business Services, Health and Medical, Sport and Recreation, Information Technology, Science and Engineering | 30-50 | info@medlumics.com | https://www.medlumics.com/ | ||
Schlieren, Switzerland | Other +1 Other, Science and Engineering | 20-30 | info@memo-therapeutics.com | https://memo-therapeutics.com/home.html |
50/764 results
Free Preview - Top 50 companies
Export Free JSON (50)
Frequently asked questions
FAQ updated November 2025
What is Enterprise League?
Enterprise League is a business platform built for the doers, small businesses and startups who want to get seen, get leads, and grow.We help you showcase your company, connect directly with potential clients and partners, and get valuable insights into your performance, all without the middlemen or the fluff. Whether you're a team of 2 or 200, Enterprise League puts you on equal ground with the big players.
How can my business benefit from joining Enterprise League?
You get visibility, leads, and control, all in one place. Joining Enterprise League puts your business in front of thousands of verified companies. List your services, connect with decision-makers, and see real-time data on who’s visiting your profile.It’s a streamlined way to grow your presence, build partnerships, and stop relying on outdated directories or cold outreach.
What are the key features of Enterprise League?
Enterprise League gives you tools to grow faster: • Custom Profiles:Boos your visibility with a standout business profile. • Smart search: Get found by clients looking for your exact services. • Real analytics: See who's visiting, what's working and where you rank. • Direct messaging: Skip the cold emails and chat direct with prospects. • Reviews insights: Showcase real reviews and let AI highlight what matters. • Zero-fee marketplace: List and find products or services for free.
How does the company verification process work?
Get verified for the price of a coffee $0 Verified companies appear higher in search, build trust faster, and unlock an extra features. One badge. More business.
Can I try Enterprise League for free?
Absolutely. Our Free Plan is built for small businesses. You get profile visibility, marketplace access, and business directory use, free. Want more reach and features? Upgrade when you’re ready. No pressure.
How does the Interactive Business Directory work?
It’s like Google, but only for serious businesses. Search by location, size, or sector. Visit company profiles, send a message, or download insights. It’s built for real B2B decisions, not noise.
How can I download business insights?
Need competitor or market data? We’ve got it, and yes, you can download it. With our Business Insights Download feature, you can export detailed company and industry data in CSV format, including decision-makers, background info, and more. It’s perfect for sales targeting, market research, or just getting smarter about your next move.
What is the Referral Program?
Invite a business friend. You both get rewarded. Refer another company and when they join, you both get 1 month of Premium — free. It’s our way of growing the community with good people.
How does the Reviews feature work?
Show off your best reviews, without lifting a finger. We pull your reviews from Google, Facebook, Trustpilot and more. Then our AI highlights the most important insights. You just sit back and shine.
What plans are available?
Three simple plans: Free Plan: Get started with a verified profile, search access, and marketplace listing. Premium: More reach, more leads, deeper analytics. Ultimate: All the bells and whistles, including a dedicated growth partner.
How can my company win an award?
We highlight the best of the best, and that could be you. We run 50+ startup award categories every year. Apply for free. Winners get recognition, visibility, and bragging rights.